OIG September 2017 Summary:
“Drug Supply Chain Security: Wholesalers Exchange Most Tracing Information”
The Office of Inspector General (OIG) issued its first in a series of examinations of drug supply chain security that will outline provisions for the implementation the Drug Supply Chain Security Act (DSCSA).
This Report Discusses:
- The Office of Inspector General’s methodology
- Key findings from the report
- Recommendations based on The FDA & The OIG’s findings
Want to read the entire article?
Sign up for our monthly newsletters and receive exclusive news, whitepapers, and more about the Pharmaceutical and Healthcare industry!